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The role of the cytoskeleton in capacitative calcium
entry in myenteric glia
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Abstract Capacitative calcium entry (CCE) is the pro-
cess by which intracellular calcium is replenished from
the external milieu upon depletion of intracellular
stores. CCE is thought to participate in chemotaxis,
proliferation and cell signalling. A physical interaction
between intracellular stores and the plasma membrane
is postulated to regulate CCE. We hypothesized that
cytoskeletal disruption alters this interaction, inhibit-
ing CCE in enteric glia. Cultured myenteric glia from
neonatal guinea-pigs were treated with cytochalasin D
(10 lmol L)1), a microfilament disrupting agent,
nocodazole (20 lmol L)1), a microtubule disrupting
agent, or vehicle (dimethyl sulphoxide). Intracellular
calcium changes were measured using fura-2 micro-
fluorimetry. To evaluate the rate of cation re-entry,
barium was substituted for calcium because barium is
not sequestered internally. Cytochalasin D-treated glia
had diminished CCE responses (57 ± 3 nmol L)1)
compared with controls (97 ± 7 nmol L)1) as did
nocodazole-treated glia (30 ± 2 nmol L)1) vs controls
(77 ± 6 nmol L)1). The proportion of cells demonstra-
ting CCE abolition was greater in the cytochalasin
(50 ± 8%) and nocodazole-treated (89 ± 2%) groups
compared with controls (21 ± 2%, 40 ± 9%, respect-
ively). Cytochalasin D and nocodazole treatment di-
minished the rate of cation re-entry based on
diminished barium entry in treated vs control cells.
From this study, we conclude that disruption of cyto-
skeletal elements diminishes calcium influx essential
to calcium store repletion in myenteric glia.
Keywords capacitative calcium entry, cytochalasin,
enteric glia, nocodazole.
INTRODUCTION
The enteric nervous system (ENS) is a major regula-
tor of gastrointestinal function with a diversity of
control ranging from regulation of blood flow to
motility. The ENS spans the length of the gastroin-
testinal tract and is situated between the muscular
layers of the gut. Two major cell types comprise the
ENS, neurones and glial cells. Glia have long been
regarded to serve predominantly adjunctive roles in
support of neurones within the ENS. A growing body
of evidence, however, suggests that glia have an
important role within the ENS environment.1 Ruhl
et al. have demonstrated that cultured myenteric glia
are responsive to interleukin-1b by producing inter-
leukin-6.2 Maudlej and Hanani showed dye coupling
among enteric glia.3 Studies from our laboratory have
shown that within the ENS, myenteric glia partici-
pate in intercellular communication amongst glial
cells via calcium wave propagation.4 Preliminary data
from these ongoing studies also suggests the propa-
gation of waves between enteric neurones and glia
(Zhang et al.). We postulate that the ability of
myenteric glia to respond to molecules through
established signal transduction pathways may be
essential to the functionality of the ENS. Previous
work from our laboratory has demonstrated that
enteric glia are responsive to a number of neurolig-
ands including adenosine triphosphate (ATP), bradyk-
inin, histamine and endothelin through calcium
signalling.5,6
Enteric glia demonstrate capacitative calcium entry
(CCE), a component of cellular calcium regulation,
first proposed by Putney.7,8 In CCE, intracellular
calcium is replenished by calcium entry from the
extracellular milieu upon intracellular calcium store
depletion. CCE has been demonstrated in numerous
cells types and is regarded to be characteristic of
predominantly non-excitable cells. CCE is postulated
to participate in processes as disparate as signal
transduction, chemotaxis, and proliferation, possibly
Address for correspondence
Michael Mulholland, M.D., Ph.D.,
2101 Taubman Center, 1500 E Medical Center Drive,
Ann Arbor, MI 48109-0346, USA.
Tel.: (734) 936-3236; fax: (734) 763-5615;
e-mail: micham@umich.edu
Received: 13 January 2003
Accepted for publication: 17 February 2003
Neurogastroenterol Motil (2003) 15, 277–287
 2003 Blackwell Publishing Ltd 277
through the ability to sustain agonist-induced calcium
transients or calcium oscillations.9,10
The mechanism by which calcium entry is stimula-
ted by the depletion of intracellular calcium stores has
been the focus of intense investigation.11 Proposed
mechanisms of CCE include: a diffusible signalling
molecule, transport of a CCE channel to the plasma
membrane after store depletion, gating of plasma
membrane-based CCE channels by localized calcium
concentration gradients, and physical coupling between
the intracellular calcium storage organelle and plasma
membrane calcium channels.12 The last, conforma-
tional coupling model, has been the focus of a number
of recent studies. Delmas et al. showed that disruption
of the actin cytoskeleton resulted in a loss of coupling
between a plasma membrane bradykinin receptor and
the IP3 receptor, causing inactivation of Trp, a potential
CCE channel.13 Other studies involving disruption of
protein–protein interactions between the calcium stor-
age organelle and the plasma membrane by destabil-
izing cytoskeletal elements (microfilaments and
microtubules) have yielded conflicting results.14,15
The potential relationship of the cellular cytoskele-
tal architecture to the mechanisms of CCE in enteric
glia has not been reported. We sought to investigate the
role of the cytoskeleton in the regulation of CCE in
enteric glia by pharmacological disruption of actin
microfilaments with cytochalasin D or tubulin micro-
tubules with nocodazole. The results of this study
demonstrate that the cytoskeleton is integral to CCE
regulation in enteric glia.
MATERIALS AND METHODS
Materials
Fura-2 acetoxymethyl ester (fura-2/AM), fura-2 free
acid, Alexa Fluor 488 phalloidin, and 4¢,6-diamidino-
2-phenylindole, dihydrochloride (DAPI) were obtained
from Molecular Probes (Eugene, OR, USA). ATP,
collagenase type IV, trypsin–ethylenediaminetetraace-
tic acid (EDTA), soya bean trypsin inhibitor (type I-S),
penicillin–streptomycin solution, HEPES, dimethyl
sulphoxide, glucose ethylene-bis (oxyeth yenenitrilo)
tetraacetic acid, EGTA, barium, cytochalasin D and
nocodazole were purchased from Sigma Chemical (St
Louis, MO, USA). Anti-b-tubulin antibody and goat
anti-mouse IgG-FITC secondary antibody were
obtained from Santa Cruz Biotechnology (Santa Cruz,
CA, USA). Goat normal serum was from Vector
Laboratories (Burlingame, CA, USA).
Hank’s balanced salt solution, medium 199,
L-glutamine, MEM amino acids, HEPES, and sodium
pyruvate were from Gibco BRL (Grand Island, NY,
USA). NU-serum I was from Becton Dickinson
(Bedford, MA, USA). Two-day-old male Duncan–
Hartley guinea-pigs were obtained from Simonsen
Labs (Gilroy, CA, USA).
Cultures of myenteric glia
Dispersed primary cultures of guinea-pig myenteric glia
were prepared on collagen-coated coverslips and used for
experiments within 5–8 days. In brief, the taenia coli
from 2-day-old male Duncan–Hartley guinea-pigs were
removed from the caecum and placed in Hank’s bal-
anced salt solution plus 0.1% collagenase (type IV) for
16–20 h at 4 C. After 35-min incubation at 37 C, the
myenteric plexus of the taenia coli was separated from
the investing muscle layers under a dissecting micro-
scope. The plexus was incubated for 30 min at 37 C
using trypsin–EDTA (0.5 g/L trypsin, 0.5 mmol L)1
EDTA) solution, triturated with pipettes of decreasing
tip diameter, and plated on collagen-coated coverslips.
Cultures were maintained in medium 199 supplemen-
ted with 5% NU-serum I, 1 mmol L)1 sodium pyru-
vate, glucose 5 mg/ml, 0.2 mmol L)1 L-glutamine, and
0.001% trypsin inhibitor (type I-S from soya bean).
Penicillin–streptomycin solution was added for the first
48 h at 2% concentration. Thereafter, media, devoid of
antibiotics, was changed every other day. No anti-
mitotic agents were used. The cultures were incubated
at 37 C with 5% CO2 and used for study within
5–8 days of preparation.
Solutions
All experiments were performed in standardized solu-
tions except when noted. Standard calcium control
buffer was a modified Krebs–Ringer solution containing
118 mmol L)1 NaCl, 4.7 mmol L)1 KCl, 1.8 mmol L)1
CaCl2, 10 mmol L
)1 4-(2-hydroxyethyl)piperazine-
1-ethane sulfonic acid HEPES, 15 mmol L)1 NaHCO3,
11 mmol L)1 glucose, 0.9 mmol L)1 NaH2PO3,
0.8 mmol L)1 MgSO4, pH 7.40. For calcium-free con-
trol buffer, CaCl2 was removed and 1 mmol L
)1 EGTA
was added. In experiments in which barium
(4 mmol L)1) was used, HCO3 , S2O
2
4 , and H2PO

4
were removed as they form insoluble salts with barium.
Cytoskeletal disruption
To investigate the effect of cytoskeletal disruption on
CCE regulation, cytochalasin D (0.1–10 lmol L)1) or
nocodazole (1–20 lmol L)1) was added to culture
media to disrupt actin microfilaments and tubulin
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microtubules, respectively.15,16 Dimethyl sulphoxide
(DMSO) was added to glial culture media as a
control. The amount of DMSO added as vehicle did
not exceed 1%. For microfilament experiments,
cytochalasin D-treated and control groups were incu-
bated at 37 C for 40 min. For the microtubule
experiments, nocodazole-treated and control groups
were incubated at 37 C for 120 min. Cells were
examined using phase contrast microscopy for evi-
dence of cytoskeletal disruption prior to calcium
imaging. Incubation of glia with cytochalasin D or
nocodazole for the times of 40 and 120 min, respect-
ively, were determined by assessing for evidence of
morphologic change at multiple time points after
drug treatment under light microscopy. Evidence of
structural change was most consistently reproduced
at the selected times, 40 and 120 min.
Loading and cell preparation for imaging
Treated and control glia were incubated at 37 C in fresh
warmed media containing 0.5 lmol L)1 fura-2-AM for
45 min following treatment. Loaded coverslips were
washed, resuspended in calcium control buffer, and
placed in a Lucite superfusion chamber on a warmed
(37 C) microscope stage. In all experiments, the rate of
superfusion was constant at 1 mL min)1 and main-
tained at 37 C.
Intracellular calcium measurement
Single-cell intracellular calcium measurements were
performed on treated and control glia using fura-2-
based fluorimetry. A Zeiss Axiovert inverted micro-
scope and Attofluor digital imaging system
(Rockville, MD, USA) were used for single-cell intra-
cellular calcium ([Ca2+]i) measurements. [Ca
2+]i was
determined from the ratio of fluorescence intensity of
fura-2 at 334 and 380 nmol L)1, with an emission
wavelength of 540 nmol L)1. Calibration of the system
was performed with the two-point standardization
equation using fura-2-free acid:
½Ca2þi ¼ Kd½ðR  RLoÞ=ðRHi  RÞb
where Kd ¼ dissociation constant of the Ca2+/fura-2
complex (225 nmol L)1), R ¼ F334/F380, i.e. the fluor-
escence at 334-nm excitation divided by the fluores-
cence at 380-nm excitation, RLo ¼ ratio at zero
calcium (1 mmol L)1 EGTA), RHi ¼ ratio at high cal-
cium (1 mmol L)1 CaCl2), and b ¼ F380 (zero Ca2+)/F380
(saturating Ca2+). A ratio pair was measured every
1.5 s.
To elicit CCE, a standardized protocol was util-
ized.5,7 All cells were initially exposed to calcium
control buffer and then placed in calcium-free
buffer containing EGTA. Cells were exposed to
ATP (100 lmol L)1), a known IP3-mediated calcium-
mobilizing agonist, in the absence of calcium for
200 s, followed by calcium-free buffer containing
EGTA.6 Calcium was then returned to the extra-
cellular environment for the remainder of the
experiment.
In a separate group of experiments, barium
(4 mmol L)1) was substituted for calcium to charac-
terize ion entry into glial cells after treatment with
vehicle, cytochalasin D, or nocodazole. Barium ions
cause fura-2 fluorescence ratio changes in a similar
manner to calcium ions. Barium, in contrast to
calcium, cannot be sequestered in internal stores and
thus is representative of cation entry from extracellular
sources.7 In these experiments, the imaging system
was not calibrated and the data were recorded as the
ratio of F334 to F380.
Fluorescence microscopy
Primary glial cells grown on coverslips treated for the
respective times with vehicle, cytochalasin D
(10 lmol L)1), or nocodazole (20 lmol L)1) were fixed
in 4% para-formaldehyde in phosphate-buffered saline
(PBS) at 4 C, washed twice in PBS, then permeabilized
with 0.1% Triton X-100 for 5 min at room tempera-
ture. To define the actin microfilaments in control and
cytochalasin D-treated cells, Alexa Fluor 488 phalloi-
din (Molecular Probes Eugene, OR, USA) was used.
Phalloidin, derived from the Amanita phalloides
mushroom, binds competitively to F-actin and acts as
a specific F-actin probe. This probe has been used to
specifically stain F-actin in a study by Yamamoto and
Kiss.17 In accordance with the manufacturer’s staining
protocol, a 1 : 40 dilution of Alexa Fluor 488 phalloi-
din was used to stain microfilaments. To reduce non-
specific staining, 1% bovine serum albumin (BSA) was
added to the staining solution. Coverslips were stained
for 20 min at room temperature and subsequently
washed at least twice with PBS. For microtubule
staining, a monoclonal antibody against b-tubulin
was employed (Santa Cruz Biotechnology, Inc., Santa
Cruz, CA, USA) in analogy to similar probes used to
specifically stain b-tubulin.15,18 Fixed control and
nocodazole-treated cells were incubated in 10% nor-
mal blocking serum made with goat normal serum
(Vector Laboratories, Burlingame, CA, USA) for 20 min
at room temperature to suppress non-specific binding.
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After washing in PBS, cells were incubated with anti-b-
tubulin antibody overnight at 4 C. Secondary anti-
body, goat anti-mouse IgG-FITC, was diluted 1 : 50 and
coverslips were incubated for 1 h at room temperature.
Coverslips were washed twice in PBS. Cells were then
treated with 4¢,6-diamidino-2-phenylindole, dihydro-
chloride (DAPI) as a nuclear counterstain at 1 : 300
dilution for 5 min. Coverslips were mounted on glass
slides and stored in a light-impermeant box until
examination using an AxioVision (Carl Zeiss Inter-
national, Thornwood, NY, USA) software-based Zeiss
Axiophot-2 fluorescent microscope equipped with a
Zeiss Axiocam digital camera for image capturing.
Data analysis and presentation
Data are expressed as mean ± SEM. Experiments were
performed for control and treated groups from at least
three different culture preparations. Each culture
preparation required at least three animals. Only one
microscope field per coverslip was examined. Individ-
ual cells within a microscopic field were studied by
using Attofluor Ratiovision (Atto Bioscience, Rock-
ville, MD, USA) software, version 6.00, which allowed
for selection of individual regions of interest to be
examined. Cells with basal [Ca2+]i > 100 nmol L
)1
were excluded as glia with high [Ca2+]i prior to any
stimulation were considered to be damaged or leaky.
Cells were considered responsive if their response to
ATP was >50 nmol L)1 over baseline. CCE was
defined by the rise in [Ca2+]i that occurred after the
return of calcium to the extracellular environment
after the depletion of internal stores in the absence of
extracellular calcium. The increment of CCE (D
calcium) was determined by measuring the peak and
baseline [Ca2+]i and calculating the difference. In this
study, we defined a cell to have an inhibited CCE
response when D calcium <50 nmol L)1. To quantita-
tively assess the proportion of cells in treated and
control groups with inhibited CCE responses, the
number of cells with D calcium <50 nmol L)1 was
compared with the total number of responsive cells
within a given set of cultures. These data were
represented as percentage of cells inhibited. In the
barium influx measurements, the rate of entry was
determined by calculating the slope, which was
defined as the change in ratio of F334 to F380 over a
constant time interval (250 s). The slope was desig-
nated in arbitrary units. One-way ANOVA and Student’s
unpaired t-test were carried out using GraphPad Prism
version 3.02 (Graphpad Software, San Diego, CA,
USA) to determine statistical significance. P values
<0.05 were considered significant. In this study,
n equals the number of cells examined, except in data
represented as percentage of cells inhibited, where n
equals the number of separate culture preparations.
RESULTS
Enteric glia are responsive to ATP
and demonstrate CCE
Enteric glia have been shown from previous work to be
responsive to ATP with mobilization of internal
calcium stores through an IP3-mediated pathway,
inducing capacitative entry when calcium is returned
to the external environment.5,7 We used this estab-
lished protocol as the basis for the experiments in this
study. Cultured glia were exposed to 100 lmol L)1
ATP, prepared in calcium-free buffer, for 200 s to
induce release of calcium from intracellular stores.
[Ca2+]i was allowed to return to basal levels subsequent
to the agonist-induced calcium transient. Cells were
returned to calcium-free buffer and then extracellular
calcium was reintroduced into the perfusion with
control calcium buffer. Fig. 1 is a representative tracing
of a single control glial cell typical of this protocol.
We used ATP in this investigation based on previous
work performed in our laboratory by Kimball and
Mulholland.6 In our experience, ATP consistently
elicits an increase in intracellular calcium concentra-
tion in nearly 100% of cells whereas bradykinin has
been shown to elicit an increase in intracellular
calcium concentration in only 11% of cultured myen-
teric glia.6 Hence, we believe that the use of ATP over





















Figure 1 Representative tracing of enteric glia exposed to
adenosine triphosphate (100 lmol L)1) for 200 s in calcium-
free buffer (white bar). Addition of extracellular calcium (black
bar) to perfusion medium induces capacitative calcium entry.
Tracing represents a single glial cell.
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studying as many responsive glia as possible in our
assays.
Morphological changes in myenteric glia
following cytoskeletal disruption
To examine the effect of altering the cytoskeleton of
myenteric glia on CCE, actin microfilaments were
disrupted using cytochalasin D. Cytochalasin D is an
alkaloid produced by Helminthosporium and other
moulds which acts to destabilize F-actin by binding to
G-actin, the monomeric form of actin, thus creating a
state of G-actin depletion. As turnover and re-poly-
merization are constantly occurring within cells,
existing F-actin depolymerizes as the effective concen-
tration of free G-actin becomes limiting.14 Glial cells
were pretreated with 10 lmol L)1 cytochalasin D for
40 min at 37 C. Control glia were incubated with an
equal volume of vehicle, DMSO, under the same
conditions. Both groups were examined with phase
contrast microscopy as shown in Fig. 2. Control glia
were round-shaped with comparable nuclear and cyto-
plasmic volumes (Fig. 2C). In contrast, cytochalasin
D-treated glia were spiculated and condensed with loss
of significant amounts of cytoplasmic volume
(Fig. 2D). The cytoskeletal disruption was more clearly
defined with fluorescent staining of F-actin with Alexa
Fluor 488 phalloidin (Fig. 3).
The microtubule cytoskeletal network was simi-
larly investigated using nocodazole, which binds to
b-tubulin and induces microtubule depolymeriza-
tion.16 Glial cells were pretreated with 20 lmol L)1
nocodazole for 120 min at 37 C. Control glia were
incubated with an equal volume of vehicle, DMSO,
under the same conditions. Immunocytochemical
staining with anti-b-tubulin antibody revealed the
microtubule organization in control cells. Staining
appeared more sparse and perinuclear in nocodazole-
treated glia compared with vehicle-treated controls
(Fig. 4).
Effect of cytochalasin D on enteric glial CCE
To discern whether cytochalasin D has a dose-depend-
ent effect on glial CCE, increasing doses of cytochala-
sin D (0.1, 1, 10 lmol L)1) were used to treat glia for
40 min at 37 C. Evidence of cytoskeletal disruption
was assessed by light microscopy (data not shown).
Control cells treated with vehicle were examined in
Figure 3 Fluorescent staining of actin
microfilaments with AlexaFluor 488
phalloidin using fluorescent microscopy at
40· magnification. Scale bar represents
10 lm. (A) Control (vehicle-treated) cells;
and (B) cytochalasin D (10 lmol L)1)-
treated cells with marked condensation
of microfilaments.
Figure 2 Light photomicrograph of enteric glia exposed to
vehicle (control) or cytochalasin D (10 lmol L)1) at 20· mag-
nification. Scale bar represents 25 lm. (A) Control, time
0 min; (B) cytochalasin D-treated cells, time 0 min; (C) con-
trol cells after 40 min; and (D) cytochalasin D-treated cells
after 40 min.
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parallel. Intracellular calcium levels were measured
according to the previously mentioned perfusion
protocol. The changes in calcium influx in control vs
cytochalasin D-treated glia are shown in Fig. 5. Control
cells had D calcium due to CCE of 88.5 ± 5 nmol L)1
whereas cytochalasin D treatment yielded CCE of
69.3 ± 5 nmol L)1 (0.1 lmol L)1), 62.5 ± 9 nmol L)1
(1 lmol L)1) and 54.29 ± 3 nmol L)1 (10 lmol L)1).
Although there appeared to be a qualitative dose-
dependent decrease in CCE by cytochalasin D treat-
ment, statistical significance was achieved only in the
10 lmol L)1 group (P < 0.01 vs control).
Given these findings, we pursued the effect on CCE by
disruption of actin microfilaments using 10 lmol L)1
cytochalasin D. Basal [Ca2+]i levels were similar in
control and treated groups (33 ± 1 nmol L)1 vs
30 ± 0.6 nmol L)1). Cytochalasin D-treated cells dem-
onstrated a diminished CCE response (57 ± 3 nmol L)1,
n ¼ 205 cells) compared with vehicle-treated controls
(97 ± 7 nmol L)1, n ¼ 111 cells, P < 0.01) (Fig. 6A,B).
As mentioned earlier, inhibition of the CCE response
was arbitrarily defined as a change in calcium entry of
<50 nmol L)1. Determination of the number of cells
examined meeting this criteria revealed the proportion
of cells demonstrating CCE inhibition in the cytocha-
lasin D-treated (10 lmol L)1) group (50 ± 8%, n ¼ 6
separate culture preparations) was significantly greater
than the proportion of cells demonstrating CCE inhi-
bition in the control group (21 ± 2%, n ¼ 3 separate
culture preparations, P < 0.05) (Fig. 6C).
Effect of nocodazole on enteric glial CCE
To discern whether nocodazole exhibits a dose-depend-
ent effect on glial CCE, increasing doses of nocodazole
(1, 10, 20 lmol L)1) were used to treat glia for 120 min at
37 C. Evidence of cytoskeletal disruption was assessed
by light microscopy (data not shown). Control cells
treated with vehicle were examined in parallel. Intra-
cellular calcium levels were measured. The change in
calcium influx in control vs nocodazole-treated glia is
shown in Fig. 7. Control cells had D calcium due to CCE
of 63.9 ± 4 nmol L)1 whereas nocodazole treatment
yielded CCE of 31.0 ± 3 nmol L)1 (1 lmol L)1),
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Figure 5 Effect of increasing cytochalasin D dose on capacit-
ative calcium entry (CCE). Change in intracellular calcium
due to CCE in control (white bar) compared with 0.1, 1.0 and
10 lmol L)1 cytochalasin D after 40 min at 37 C. Control
cells had an increment of CCE (D calcium) due to CCE of
88.5 ± 5 nmol L)1 whereas cytochalasin D treatment yielded
CCE of 69.3 ± 5 nmol L)1 (0.1 lmol L)1, ANOVA P > 0.05 vs
control), 62.5 ± 9 nmol L)1 (1 lmol L)1, ANOVA P > 0.05 vs
control) and 54.29 ± 3 nmol L)1 (10 lmol L)1, ANOVA
*P < 0.01 vs control). More than 50 cells were examined in
each control and treatment group from at least three separate
culture preparations.
Figure 4 Immunocytochemical staining
of microtubules with anti-b-tubulin anti-
body using fluorescent microscopy at 40·
magnification. Scale bar represents 10 lm.
(A) Control (vehicle-treated) cells with
diffuse microtubule staining; and
(B) nocodazole-treated cells with con-
densed pattern of staining away from the
cell periphery.
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(20 lmol L)1). Although there appeared to be an inhib-
itory effect on CCE with these doses of nocodazole,
there was no clear graded dose responsiveness (P < 0.01
in 1, 10, 20 lmol L)1 vs control). Given the lack of clear
dose-dependent inhibition with nocodazole, we con-
ducted the remainder of the experiments with
20 lmol L)1 nocodazole for 120 min. Basal [Ca2+]i levels
were similar in control and treated groups
(45 ± 2 nmol L)1 vs 48 ± 1 nmol L)1). Cells treated
with nocodazole demonstrated a diminished CCE re-
sponse (30 ± 2 nmol L)1, n ¼ 142 cells) compared with
the control CCE response (77 ± 6 nmol L)1, n ¼ 118
cells, P < 0.01) (Fig. 8A,B). The proportion of cells
exhibiting CCE inhibition was significantly greater in































































Figure 6 Effect of cytochalasin D treatment on capacitative
calcium entry (CCE). (A) Representative single cell tracing of
enteric glia (control – black tracing; cytochalasin D – red
tracing). Cells were initially exposed to adenosine triphos-
phate (100 lmol L)1) for 200 s in calcium-free buffer (white
bar). Calcium was returned to the medium (black bar) with a
second peak due to CCE. (B) Cytochalasin D-treated cells
(black bar, 57 ± 3 nmol L)1, n ¼ 205 cells, *P < 0.01) demon-
strated a diminished CCE response compared with control
cells (white bar, 97 ± 7 nmol L)1, n ¼ 111 cells). Cells exam-
ined were from at least three separate preparations.
(C) Cytochalasin D-treated cells demonstrated a greater pro-
portion of cells with inhibited CCE (50 ± 8%, *P < 0.05, n ¼ 6
separate culture preparations) compared with control cells
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Figure 7 Effect of increasing nocodazole dose on capacitative
calcium entry (CCE). Change in intracellular calcium due to
CCE in control (white bar) compared with 1 lmol L)1,
10 lmol L)1 and 20 lmol L)1 nocodazole after 120 min at
37 C. Control cells had an increment of CCE (D calcium) due
to CCE of 63.9 ± 4 nmol L)1 whereas nocodazole treatment
yielded CCE of 31.0 ± 3 nmol L)1 (1 lmol L)1, ANOVA
*P < 0.01 vs control), 29.7 ± 3 nmol L)1 (10 lmol L)1, ANOVA
*P < 0.01 vs control), and 25.8 ± 2 nmol L)1 (20 lmol L)1,
ANOVA *P < 0.01 vs control). More than 50 cells were exam-
ined in each control and treatment group from at least three
separate culture preparations.
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culture preparations) compared with control (40 ± 9%,
n ¼ 4 separate culture preparations, P < 0.05) (Fig. 8C).
Rate of cation entry is altered
by cytoskeletal disruption
Barium was used in a separate group of experiments to
examine cation entry from the external environment.
These studies were carried out in separate experimen-
tal runs from at least three separate culture prepara-
tions. Barium, unlike calcium, cannot be sequestered
intracellularly but shares the ability to interact with
fura-2, making it a marker solely of cation influx. After
depletion of intracellular calcium stores with ATP in
the absence of extracellular calcium, barium was
introduced to the perfusing medium for an interval of
250 s. Barium more rapidly accumulated in control
(11.2 ± 0.6 AU (arbitrary units), n ¼ 97 cells) compared
with cytochalasin D-treated cells (5.9 ± 0.5 AU,
n ¼ 108 cells, P < 0.01) (Fig. 9A). In addition, barium
accumulated more rapidly in control (9.3 ± 1.5 AU,
n ¼ 43 cells) compared with nocodazole-treated cells
(2.9 ± 0.4 AU, n ¼ 30 cells, P < 0.01) (Fig. 9B).
DISCUSSION
The enteric nervous system has a major role in
regulating the local gastrointestinal environment.1
Although the effector cells of the ENS have been
believed to be solely gut neurones, recent work has
shifted attention towards enteric glia. In this study, we
demonstrate that calcium signalling in cultured enteric
glia is modulated by cytoskeletal elements, microfila-
ments and microtubules. Our findings suggest that
CCE is dependent, in part, on an intact cytoarchitec-
ture. Enteric glia undergo distinct morphological chan-
ges with disruption of microfilaments and
microtubules as assessed by light and fluorescent
microscopy. The doses of cytochalasin D and nocodaz-
ole and incubating conditions are in concert with the
ranges employed in a number of recent studies.10,14,15,19
These architectural changes did not affect measured
basal [Ca2+]i. Moreover, the ability of glia to respond to
ATP reflects their viability after pharmacological treat-
ment. CCE is significantly reduced in cells treated with
































































Figure 8 Effect of nocodazole treatment on capacitative cal-
cium entry (CCE). (A) Representative single cell tracing of
enteric glia (control – black tracing; nocodazole – red tracing).
Cells were initially exposed to adenosine triphosphate
(100 lmol L)1) for 200 s in calcium-free buffer (white bar).
Calcium was returned to the medium (black bar) with a sec-
ond peak due to CCE. (B) Nocodazole-treated cells (black bar,
30 ± 2 nmol L)1, n ¼ 142 cells,*P < 0.01) demonstrated a
diminished CCE response compared with control cells (white
bar, 77 ± 6 nmol L)1, n ¼ 118 cells) Cells examined were from
at least three separate preparations. (C) Nocodazole-treated
cells demonstrated a greater proportion of cells with inhibited
CCE (89 ± 2%, *P < 0.05, n ¼ 4 separate culture preparations)
compared with control cells (40 ± 9%, n ¼ 4 separate culture
preparations).
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fura-2 microfluorimetry. The results of the studies
using barium as a marker exclusively for cation entry
suggest that the inhibition of calcium influx following
cytoskeletal disruption with cytochalasin D and noco-
dazole is due to a decreased rate of influx possibly
attributable to structurally-dependent entry kinetics.
The cytoskeleton is a complex network composed of
microfilaments, microtubules, and intermediate fila-
ments. The cytoskeleton acts as an elastic mechanical
conduit through which information and stimuli can be
transmitted to the cell interior.
Recent work in cultured vascular smooth muscle
cells demonstrated the existence of mechanically
(stretch)-sensitive intracellular calcium stores insen-
sitive to IP3 and potentially mediated through cyto-
skeletal elements.19 Cyclical stretch produced
increases in intracellular calcium, which were inhib-
ited by pretreatment with cytochalasin D but not by
nocodazole.19 Studies in cultured rat astrocytes under-
going mechanical stimulation to evoke increases in
intracellular calcium levels were attributed to an
autocrine release of ATP and subsequent activation of
the phopholipase C/IP3 pathway of calcium release.20
The authors postulate that mechanical stimulation
induces the release of ATP through deformation of
cytoskeletal elements.20 A review by Janmey details
the effects of the cytoskeleton on cellular functions,
including the regulation of transmembrane ion
fluxes.21 Cytoskeletal regulation of ion flux has been
proposed to occur via transduction of mechanical stress
at the plasma membrane to membrane-localized ion
channels. Membrane deformation may open or close
these channels. This construct is consistent with the
blunted CCE response demonstrated in our experi-
ments as the disrupted cytoskeletal elements may alter
signalling to membrane-based calcium channels. The
possibility exists that mechanical stimulation via the
continuous flow of the perfusion apparatus may con-
tribute to cellular calcium signalling processes in
myenteric glia. However, the rate of flow was constant
and unchangeable in the current system; thus, the
fixed rate of flow would likely supply a uniform
stimulus in both treated and control groups. Similar
initial basal calcium levels between control and treat-
ment groups support a minimal or uniformly applied
effect on glia from the perfusion system.
Numerous models have been proposed to explain
CCE. The conformational coupling model, in which
protein–protein interactions facilitate signal transduc-
tion from the intracellular calcium storage organelle
and the plasma membrane calcium channel, has been
the most widely investigated. The present study sug-
gests that cytoskeletal scaffolding of polymerized mol-
ecules of actin and tubulin mediate a key portion of the
transduction mechanism involved in signalling intra-
cellular calcium depletion to the plasma membrane in
myenteric glia. However, controversy exists regarding
the role of the cytoskeleton in CCE. Blatter and Holda





































Figure 9 Effect of cytochalasin D and nocodazole on rate of
cation re-entry following calcium store depletion. After
depletion of intracellular calcium stores with adenosine tri-
phosphate in the absence of extracellular calcium, barium was
introduced to the perfusing medium for 250 s. (A) Barium
more rapidly accumulated in control (white bar,
11.2 ± 0.6 AU (arbitrary units), n ¼ 97 cells) compared with
cytochalasin D-treated cells (black bar, 5.9 ± 0.5 AU, n ¼ 108
cells, *P < 0.01). Three separate culture preparations
represented. (B) Barium accumulated more rapidly in control
(white bar, 9.3 ± 1.5 AU, n ¼ 43 cells) compared with noco-
dazole-treated cells (black bar, 2.9 ± 0.4 AU, n ¼ 30 cells,
*P < 0.01). Three separate culture preparations represented.
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disruption with cytochalasin D obliterated CCE, while
ATP-evoked calcium transients remained unchanged.14
Their results support a conformational coupling model
of CCE, either through physical proximity of the plasma
membrane and the endoplasmic reticulum or through
transduction of information through intact microfila-
ments. In contrast, in NIH 3T3 cells, Ribeiro found that
cytoskeletal disruption abolished only agonist-induced
calcium release, while the CCE response was unaffec-
ted.15 The investigators concluded that abolition of
agonist-induced calcium mobilization was based on an
altered spatial relationship between phospholipase C
and IP3 receptors, while CCE was mediated by a
diffusible messenger.15 Most recently, in cultured vas-
cular endothelial cells, capacitative calcium entry was
found to require both IP3 receptor binding as well as an
intact actin cytoskeleton.22
In astrocytes, Sergeeva has shown that cytoskeletal
disruption with cytochalasin D attenuates cell cal-
cium oscillations in response to ATP.10 This alteration
in calcium signalling was attributed to a diminished
CCE response in treated cells, which interfered with
the refilling of intracellular calcium stores required for
oscillations. Patterson proposed a dynamic secretion-
like coupling model regulating CCE in DDT1MF-2 and
A7r5 cells.23 In that study, a subcortical layer of F-
actin was chemically induced using both Calyculin A,
a phosphatase inhibitor, and jasplakinolide, a mem-
brane-permeant peptide. A peripherally-located ring of
F-actin was reorganized subjacent to the plasma
membrane with these agents. CCE was inhibited in
treated cells but was restored after incubation with
cytochalasin D in the Calyculin A-treated group. The
authors proposed that instead of a static cytoskeletal
architecture permanently coupling the endoplasmic
reticulum (ER) to the plasma membrane, a dynamic,
reversible scaffolding acts as the mediator between
these structures.23 Rosado, in work performed on
human platelets, similarly proposed that reversible
trafficking in a manner akin to vesicle transport
between the ER and plasma membrane is involved in
CCE.24
The distinct and sometimes conflicting findings in
the investigation of CCE from the present study and in
other published studies may in part lie in the differen-
tial distribution and content of cytoskeletal elements
amongst different cell types and species. Furthermore,
a given cell type may have a greater or lower depend-
ence on the cytoskeleton to convey calcium signals
compared with other cell types. Finally, the redund-
ancy of nature suggests that multiple pathways may
coexist to regulate such a vitally important biological
mediator as calcium.
The results of our study demonstrate that enteric
glial calcium signalling is dependent on an intact
microfilament and microtubule cytoskeleton. In con-
cert with the findings of other investigations into the
role of the cytoskeleton in CCE in a diversity of cell
types, we conclude that the cytoskeleton plays an
integral role in communicating the state of intracellu-
lar calcium stores to facilitate their replenishment
from the external environment.11,12,14,22,24 Hence, in
myenteric glia, the cytoskeleton physically couples the
plasma membrane and endoplasmic reticulum to faci-
litate calcium store repletion.
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Capacitative calcium entry. News Physiol Sci 1998; 13:
157–63.
286  2003 Blackwell Publishing Ltd
T. Lin et al. Neurogastroenterology and Motility
12 Putney JW Jr, Broad LM, Braun FJ, Lievremont JP, Bird GS.
Mechanisms of capacitative calcium entry. J Cell Sci 2001;
114 (Pt 12): 2223–9.
13 Delmas P, Wanaverbecq N, Abogadie FC, Mistry M, Brown
DA. Signaling microdomains define the specificity of
receptor-mediated InsP(3) pathways in neurons. Neuron
2002; 34: 209–20.
14 Holda JR, Blatter LA. Capacitative calcium entry is
inhibited in vascular endothelial cells by disruption of
cytoskeletal microfilaments. FEBS Lett 1997; 403: 191–6.
15 Ribeiro CM, Reece J, Putney JW Jr. Role of the cytoskele-
ton in calcium signaling in NIH 3T3 cells. An intact cy-
toskeleton is required for agonist-induced [Ca2+]i signaling,
but not for capacitative calcium entry. J Biol Chem 1997;
272: 26 555–61.
16 Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson J,
eds. Molecular Biology of the Cell, 3rd edn. New York:
Garland Publishing, 1994.
17 Yamamoto K, Kiss JZ. Disruption of the actin cytoskele-
ton results in the promotion of gravitropism in inflores-
cence stems and hypocotyls of Arabidopsis. Plant Physiol
2002; 128: 669–81.
18 Wolf KW, Winking H. The organization of microtubules
and filamentous actin in cytospin preparations of Sertoli
cells from w/wwei mutant mice devoid of germ cells. Anat
Embryol 1996; 193: 413–7.
19 Mohanty MJ, Li X. Stretch-induced Ca2+ release via an IP3-
insensitive Ca2+ channel. Am J Physiol Cell Physiol 2002;
283: C456–62.
20 Shiga H, Tojima T, Ito E. Ca2+ signaling regulated by
an ATP-dependent autocrine mechanism in astrocytes.
Neuroreport 2001; 12: 2619–22.
21 Janmey PA. The cytoskeleton and cell signaling: compo-
nent localization and mechanical coupling. Physiol Rev
1998; 78: 763–81.
22 Bishara NB, Murphy TV, Hill MA. Capacitative Ca2+ entry
in vascular endothelial cells is mediated via pathways
sensitive to 2 aminoethoxydiphenyl borate and xesto-
spongin C. Br J Pharmacol 2002; 135: 119–28.
23 Patterson RL, van Rossum DB, Gill DL. Store-operated
Ca2+ entry: evidence for a secretion-like coupling model.
Cell 1999; 98: 487–99.
24 Rosado JA, Jenner S, Sage SO. A role for the actin cyto-
skeleton in the initiation and maintenance of store-
mediated calcium entry in human platelets. Evidence
for conformational coupling. J Biol Chem 2000; 275:
7527–33.
 2003 Blackwell Publishing Ltd 287
Volume 15, Number 3, June 2003 Cytoskeleton and capacitative calcium entry
